Dr. Fehniger is a Professor of Medicine at Washington University School of Medicine in St. Louis (WashU). As a physician-scientist, he leads a research program focused on basic, translational, and early phase clinical trials, primarily focused on NK cells and ILCs. He serves as the President of the SNI.